跳至主要内容
临床试验/CTRI/2025/03/081887
CTRI/2025/03/081887招募中不适用

A prospective observational study to assess the predictive value of simple blood count based marker versus advanced cytokine biomarker for outcomes in off-pump coronary artery bypass surgery

DR SARAH IQBAL1 个研究点 分布在 1 个国家目标入组 80 人开始时间: 2025年3月20日最近更新:

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
80
试验地点
1
主要终点
Acute Kidney Injury (AKI) in off-pump coronary artery bypass grafting

研究概览

简要总结

Keeping in mind the inflammatory background of coronary artery disease, currently various inflammatory markers are being used to predict the outcomes in patients of off pump cardiac surgery like IL-1, IL-6, TNF- alpha etc. Since these tests are very costly and there is growing evidence presenting the role of  whole blood count inflammatory markers in  prediction of morbidity and mortality in coronary artery diseases we are planning this observational study to assess the predictive value of simple blood count based markers versus advanced cytokine biomarkers for outcomes in off-pump coronary artery bypass surgery.

研究设计

研究类型
Observational

入排标准

年龄范围
18.00 Year(s) 至 65.00 Year(s)(—)
性别
All

入选标准

  • Patients undergoing elective off pump Coronary Artery Bypass Grafting.
  • Isolated CABG as per ESC/EACTS 2018 guidelines Age more than 18 years Either sex.

排除标准

  • Patient refusal Patient undergoing repeat surgical procedures.
  • Patients receiving steroid, NSAIDS, immunomodulatory therapy Patients having chronic HTN, chronic renal failure, serum ALT or AST level of twice the baseline value, active infection (preoperative total leukocyte count of more than 11.000/mm3) Those having history of recent CVA or MI (within 1 month) Severe LV dysfunction (LVEF less than 30%) Pre existing AF or utilizing antiarrhythmic therapy Preexisting neurological disease Patients of oncologic diseases.

结局指标

主要结局

Acute Kidney Injury (AKI) in off-pump coronary artery bypass grafting

时间窗: 48 HOURS

次要结局

  • 1- Atrial Fibrillation ( AF), and 3 Point Major Adverse Cardiovascular(Events (3P-MACE) which includes coronary heart disease death, fatal or)

研究者

发起方
DR SARAH IQBAL
申办方类型
Other [self]
责任方
Principal Investigator
主要研究者

Dr Sarah Iqbal

Jawaharlal Nehru Medical College, Aligarh Muslim University

研究点 (1)

Loading locations...

相似试验